Csl Ltd has released a press release.
2017 FY Results Announcement and Analysts Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CSL
- Appendix 4E, Directors Report and Financial Statements
- CSL Completes Acquisition of Majority Stake in Ruide
- CSL Response to Patent Infringement Complaint
- FDA approves CSL Berhings HAEGARDA
- CSL to Acquire Majority Stake in Chinese Plasma Fractionator
Later from CSL
- CSL Behring Acquires US Biotech Company Calimmune
- FDA Approves Privigen for CIDP Indication
- New Debt Facilities
- CEOs AGM Presentation
- CSL Lifts Profit Guidance
Follow CSL into a list and get an email when it puts out news.
Follow CSL